Previous close | 1.3000 |
Open | 1.3000 |
Bid | 1.9500 |
Ask | 2.5000 |
Strike | 5.00 |
Expiry date | 2025-01-17 |
Day's range | 1.3000 - 1.3000 |
Contract range | N/A |
Volume | |
Open interest | 9 |
Kodiak Sciences (KOD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat a broad spectrum of retinal diseases, announced today that management will present at the following upcoming investor conferences:
Kodiak (KOD) reports better-than-expected first-quarter 2024 results and provides updates regarding its pipeline development plans.